Venture Capital Investors

Pontifax Fund

Pontifax Fund is a venture capital investment firm that helps tech entrepreneurs.

Venture Investor Overview

Venture Investor
Pontifax Fund
Status
InActive
Investor Type
Venture Capital
Activity Level
30 transactions
Funds Raised
At least $105 million
Industry Focus
AgTech
Biopharmaceutical

Contact Information

Contact
Phil Erlanger
Title
Managing Partner
Mailing Address
2025 S Westgate Ave. 1st Floor
Los Angeles, CA 90025
USA
Phone
323-306-9970
Website
www.pontifaxagtech.com
Email Address
[email protected]

Background Information

Overview
The firm invests in medical device and other life science related companies.
Profile
Pontifax Fund LinkedIn Company Profile
Social Media
Pontifax Fund Company Twitter Account
Company News
Pontifax Fund News
Facebook
Pontifax Fund on Facebook
YouTube
Pontifax Fund on YouTube
Last Transaction
1/9/2023

Transaction History

Our records indicate that Pontifax Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Amolyt Pharma
1/9/2023
$138,000,000
Anuvia Plant Nutrients
4/25/2022
$65,500,000
Precirix
3/24/2022
Unknown
Precirix
3/24/2022
$87,900,000
V-Wave
12/21/2021
$98,000,000
Antios Therapeutics
11/6/2021
$75,000,000
Vanqua Bio
9/15/2021
$85,000,000
Theseus Pharmaceuticals
4/14/2021
$100,000,000
StrideBio
3/17/2021
$81,500,000
Abcuro
1/8/2021
$42,000,000
Silverback Therapeutics
9/24/2020
$85,000,000
Silverback Therapeutics
3/12/2020
$78,500,000
Eyevensys
1/9/2020
$30,000,000
Adicet Bio
10/4/2019
$80,000,000
Prevail Therapeutics
3/28/2019
$50,000,000
Keros Therapeutics
1/9/2019
$23,000,000
89Bio
10/26/2018
$60,000,000
Prevail Therapeutics
3/9/2018
$75,000,000
Eloxx Pharma
8/3/2017
$8,000,000
Tisbury Pharmaceuticals
6/17/2017
$32,000,000
Eloxx Pharma
6/12/2017
$24,000,000
Anuvia Plant Nutrients
11/8/2016
$23,000,000
Eyevensys
9/16/2016
$10,116,900
Caribou Biosciences
5/16/2016
$30,000,000
Adicet Bio
1/28/2016
$51,000,000
V-Wave
1/12/2016
$28,000,000
Blue River Technology
12/16/2015
$17,000,000
AgBiome
8/20/2015
$34,500,000
Kite Pharma
5/15/2013
$20,000,000
Collplant
4/13/2007
$2,500,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
Ben Belldegrun
  Ben Belldegrun LinkedIn Profile  Ben Belldegrun Twitter Account  Ben Belldegrun News  Ben Belldegrun on Facebook
Managing Partner
Phil Erlanger
  Phil Erlanger LinkedIn Profile  Phil Erlanger Twitter Account  Phil Erlanger News  Phil Erlanger on Facebook

 

Funds

Our database includes the following fund closing(s) for Pontifax Fund. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Pontifax Global Food and Agriculture Technology Fund
10/11/2017
$105,000,000

 

Portfolio Companies

Pontifax Fund has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
89Bio
Abcuro
Adicet Bio
AgBiome
Amolyt Pharma
Antios Therapeutics
Anuvia Plant Nutrients
Blue River Technology
Caribou Biosciences
Collplant
Eloxx Pharma
Eyevensys
Keros Therapeutics
Kite Pharma
Precirix
Prevail Therapeutics
Silverback Therapeutics
StrideBio
Theseus Pharmaceuticals
Tisbury Pharmaceuticals
V-Wave
Vanqua Bio

 

 

 

 

Browse more venture capital investors:

Pontifax AgTech | Pontifax Venture Capital

 

Share this article

 

About Our Venture Capital Investors Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.